MedTrace Logo

A Study of Immune Responses to the Virus That Causes COVID-19

NCT04431414 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 953

Last updated 2022-07-26

No results posted yet for this study

Summary

The purpose of this study is to learn more about the acute response to infection with and recovery from the virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Some people know this virus by the name "coronavirus." It can cause the disease called COVID-19.

The information gained from the study can be used to help develop better tests for SARS-CoV-2 infection and COVID-19 disease and may help in developing future vaccines, other prevention strategies, and treatments.

Conditions

Interventions

OTHER

Sample collection

* blood, nasal swab, nasal wash, and saliva * optional stool swab

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • COVID-19 Prevention Network

    lead NETWORK

Principal Investigators

  • Will Hahn · Fred Hutch

  • Amy Ward · Cape Town - Khayelitsha

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-20
Primary Completion
2022-06-02
Completion
2022-06-02

Countries

  • United States
  • Argentina
  • Botswana
  • Brazil
  • Malawi
  • Mexico
  • Peru
  • South Africa
  • Tanzania
  • Zambia
  • Zimbabwe

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04431414 on ClinicalTrials.gov